XML 97 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Basic EPS        
Net earnings attributable to AbbVie Inc. $ 186 $ 1,561 $ 2,410 $ 4,300
Earnings allocated to participating securities 10 10 30 30
Earnings available to common shareholders $ 176 $ 1,551 $ 2,380 $ 4,270
Weighted-average basic shares outstanding (in shares) 1,769 1,769 1,769 1,769
Basic earnings per share (in dollars per share) $ 0.10 $ 0.88 $ 1.35 $ 2.41
Diluted EPS        
Net earnings attributable to AbbVie Inc. $ 186 $ 1,561 $ 2,410 $ 4,300
Earnings allocated to participating securities 10 10 30 30
Earnings available to common shareholders $ 176 $ 1,551 $ 2,380 $ 4,270
Weighted-average basic shares outstanding (in shares) 1,769 1,769 1,769 1,769
Effect of dilutive securities (in shares) 3 3 3 3
Weighted-average diluted shares outstanding (in shares) 1,772 1,772 1,772 1,772
Diluted earnings per share (in dollars per share) $ 0.10 $ 0.88 $ 1.34 $ 2.41